[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9812085A - "método para a sìntese de derivados de quinolina" - Google Patents

"método para a sìntese de derivados de quinolina"

Info

Publication number
BR9812085A
BR9812085A BR9812085-9A BR9812085A BR9812085A BR 9812085 A BR9812085 A BR 9812085A BR 9812085 A BR9812085 A BR 9812085A BR 9812085 A BR9812085 A BR 9812085A
Authority
BR
Brazil
Prior art keywords
synthesis
quinoline derivatives
quinoline
derivatives
phenylquinoline
Prior art date
Application number
BR9812085-9A
Other languages
English (en)
Inventor
Joseph Sisko
Mark Mellinger
Conrad Kowalski
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR9812085A publication Critical patent/BR9812085A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

"MéTODO PARA A SìNTESE DE DERIVADOS DE QUINOLINA" A presente invenção refere-se a novos intermediários e processos para a preparação de compostos de quinolina farmaceuticamente ativos, que incluem (-) - (S) - N- (<244>-etilbenzil)-3-hidróxi-2-fenilquinolina-4-carboxamida.
BR9812085-9A 1997-09-17 1998-09-17 "método para a sìntese de derivados de quinolina" BR9812085A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5930397P 1997-09-17 1997-09-17
PCT/US1998/019434 WO1999014196A1 (en) 1997-09-17 1998-09-17 Method for the synthesis of quinoline derivatives

Publications (1)

Publication Number Publication Date
BR9812085A true BR9812085A (pt) 2000-09-26

Family

ID=22022126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812085-9A BR9812085A (pt) 1997-09-17 1998-09-17 "método para a sìntese de derivados de quinolina"

Country Status (32)

Country Link
US (6) US6335448B1 (pt)
EP (1) EP1017676B1 (pt)
JP (1) JP2001516744A (pt)
KR (1) KR20010024031A (pt)
CN (1) CN1125815C (pt)
AP (1) AP1201A (pt)
AR (1) AR015445A1 (pt)
AT (1) ATE353879T1 (pt)
AU (1) AU744538B2 (pt)
BG (1) BG104243A (pt)
BR (1) BR9812085A (pt)
CA (1) CA2303026A1 (pt)
DE (1) DE69837100T2 (pt)
DZ (1) DZ2607A1 (pt)
EA (1) EA002633B1 (pt)
ES (1) ES2283072T3 (pt)
HU (1) HUP0004855A3 (pt)
ID (1) ID24140A (pt)
IL (1) IL134991A0 (pt)
MA (1) MA24644A1 (pt)
MY (1) MY120237A (pt)
NO (1) NO314303B1 (pt)
NZ (1) NZ503307A (pt)
OA (1) OA11340A (pt)
PE (1) PE129299A1 (pt)
PL (1) PL339340A1 (pt)
SK (1) SK3672000A3 (pt)
TR (1) TR200000720T2 (pt)
TW (1) TW509678B (pt)
UY (2) UY25174A1 (pt)
WO (1) WO1999014196A1 (pt)
ZA (1) ZA988455B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.
JP2002540203A (ja) 1999-03-29 2002-11-26 ニューロゲン コーポレイション Ｎｋ−３および／またはｇａｂａ（ａ）受容体リガンドとしての４−置換キノリン誘導体
AP2006003685A0 (en) 2004-02-04 2006-08-31 Pfizer Prod Inc Substituted quinoline compounds
WO2006130080A2 (en) * 2005-06-03 2006-12-07 Astrazeneca Ab Quinoline derivatives as nk3 anatgonists
US20080194623A1 (en) * 2005-08-02 2008-08-14 Labaw Clifford S Method for the Synthesis of Quinoline Derivatives
US20080280949A1 (en) * 2005-08-11 2008-11-13 Astrazeneca Ab Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
AR057130A1 (es) * 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
WO2007035156A1 (en) * 2005-09-21 2007-03-29 Astrazeneca Ab N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands
WO2007086799A1 (en) * 2006-01-27 2007-08-02 Astrazeneca Ab Amide substituted quinolines
CN102924375B (zh) * 2012-06-21 2015-02-18 江苏恩华药业股份有限公司 Talnetant中间体及其制备方法和应用
CN102702099A (zh) * 2012-06-21 2012-10-03 江苏恩华药业股份有限公司 (s)-3-羟基-2-苯基-n-(1-苯基丙基)喹啉-4-甲酰胺的制备方法
CN103214416A (zh) * 2013-04-26 2013-07-24 扬州大学 一种合成多取代喹啉类化合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776290A (en) * 1957-01-01 Hydroxy cevchoninates and carboxylic
ATE246677T1 (de) * 1994-05-27 2003-08-15 Smithkline Beecham Farma Chinolinderivate als tachykinin nk3 rezeptor antagonisten
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.

Also Published As

Publication number Publication date
EA200000322A1 (ru) 2000-10-30
MA24644A1 (fr) 1999-04-01
US20020038029A1 (en) 2002-03-28
DZ2607A1 (fr) 2003-03-01
EA002633B1 (ru) 2002-08-29
IL134991A0 (en) 2001-05-20
PL339340A1 (en) 2000-12-18
UY25407A1 (es) 1999-11-17
NO20001387D0 (no) 2000-03-16
SK3672000A3 (en) 2000-09-12
ID24140A (id) 2000-07-06
US20040049031A1 (en) 2004-03-11
HUP0004855A2 (hu) 2001-06-28
AP1201A (en) 2003-09-01
US20020173657A1 (en) 2002-11-21
DE69837100T2 (de) 2007-11-22
EP1017676A4 (en) 2002-12-04
CN1278796A (zh) 2001-01-03
CN1125815C (zh) 2003-10-29
ZA988455B (en) 1999-02-17
US6335448B1 (en) 2002-01-01
PE129299A1 (es) 2000-02-19
KR20010024031A (ko) 2001-03-26
OA11340A (en) 2003-12-09
NO20001387L (no) 2000-03-16
BG104243A (en) 2001-05-31
AR015445A1 (es) 2001-05-02
EP1017676B1 (en) 2007-02-14
AU9395898A (en) 1999-04-05
DE69837100D1 (de) 2007-03-29
EP1017676A1 (en) 2000-07-12
HUP0004855A3 (en) 2001-08-28
JP2001516744A (ja) 2001-10-02
US20050171152A1 (en) 2005-08-04
TW509678B (en) 2002-11-11
TR200000720T2 (tr) 2000-08-21
NO314303B1 (no) 2003-03-03
WO1999014196A1 (en) 1999-03-25
UY25174A1 (es) 2001-07-31
AU744538B2 (en) 2002-02-28
ES2283072T3 (es) 2007-10-16
ATE353879T1 (de) 2007-03-15
NZ503307A (en) 2002-04-26
AP2000001767A0 (en) 2000-03-31
MY120237A (en) 2005-09-30
US20060189809A1 (en) 2006-08-24
CA2303026A1 (en) 1999-03-25

Similar Documents

Publication Publication Date Title
HN1998000113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
BR0113520A (pt) Processo de preparação de ácidos n-aril-antranìlicos e seus derivados
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
NO20032208D0 (no) Benzodiazepinderivater som GABA A reseptormodulatorer
BR0002073A (pt) Processo para a preparação de um composto quiral
BR9812085A (pt) &#34;método para a sìntese de derivados de quinolina&#34;
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
BR0007643A (pt) Processo para obter ésteres de (nitroximetil) fenila de derivados de aspirina, e, (hidroximetil) feniléter de derivados de aspirina
BR9804027A (pt) Novos beta-ceto ésteres
ES2184304T3 (es) Procedimiento de preparacion de un perhidro-isoindol sustituido.
SV1999000060A (es) Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv
YU78302A (sh) Derivat piridin-1-oksida i postupak za njegovu transformaciju u farmaceutski efikasna jedinjenja
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka
NO20016151L (no) Fremstilling av substituerte piperidin-4-oner
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
BR9712773A (pt) Processo para a sìntese de benzotiofenos
UY26574A1 (es) &#34; procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol&#34;.
BR0116721A (pt) Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina
DE60029979D1 (de) LIPOSOMZUSAMMENSETZUNG VON 6,9-BIS-i(2-AMINOETHYL)-AMINOöBENZOiGöISOQUINOLIN-5,10-DIONE-DIMALEAT
BR9809439A (pt) Processos para preparação de benzotiofenos
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.